Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Inspire Medical Systems, Inc.INSP · Entity 1186 | Chief Medical Officer | May 29, 2024 | May 31, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Inspire Medical Systems, Inc.
Report date May 29, 2024 · Filed May 31, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,628 |
Reported balance
After 2024-05-29 transaction · row 1
1 source rowRow 1 · 2024-05-29 · Gift · Disposed 64 · Balance 3,628 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 29, 2024 Filed May 31, 2024 20:18 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftCommon Stock | 64 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-067168 · tm2416039-1_4seq1.xml · nonDerivative · entry 1 Sparks Charisse Y · CIK 0001940873 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,628 Read SEC document |
| February 09, 2024 Filed Feb 14, 2024 02:42 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantEmployee Stock Option (Right to Buy) · Derivative | 4,376 | $0.00 Strike: $194.87 | $0.00 |
DisclosureSEC source: 0001104659-24-022566 · tm245999-5_4seq1.xml · derivative · entry 2 Sparks Charisse Y · CIK 0001940873 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,376 Underlying: Common Stock · 4,376 shares Expires 2034-02-09 F2 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on February 9, 2025. The remaining 75% of the underlying shares will vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| February 09, 2024 Filed Feb 14, 2024 02:42 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 2,694 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-022566 · tm245999-5_4seq1.xml · nonDerivative · entry 1 Sparks Charisse Y · CIK 0001940873 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,692 F1 · shares: Represents an award of restricted stock units, which vests in three equal annual installments commencing on February 9, 2025. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| January 16, 2024 Filed Jan 19, 2024 01:44 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 3 | $150.47 | $451.41 |
DisclosureSEC source: 0001104659-24-004907 · tm243653-2_4seq1.xml · nonDerivative · entry 2 Sparks Charisse Y · CIK 0001940873 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 898 F2 · shares: Represents shares of Common Stock issued in lieu of cash fees as to which the Reporting Person is entitled pursuant to the Company's Non-Employee Director Compensation Policy in respect of compensation for the third quarter of 2023 relating to her prior service as a member of the Issuer's Board of Directors. Such shares were not previously issued due to an inadvertent clerical error. Read SEC document |
| January 16, 2024 Filed Jan 19, 2024 01:44 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 2 | $325.91 | $651.82 |
DisclosureSEC source: 0001104659-24-004907 · tm243653-2_4seq1.xml · nonDerivative · entry 1 Sparks Charisse Y · CIK 0001940873 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 895 F1 · shares: Represents shares of Common Stock issued in lieu of cash fees as to which the Reporting Person is entitled pursuant to the Company's Non-Employee Director Compensation Policy in respect of compensation for the second quarter of 2023 relating to her prior service as a member of the Issuer's Board of Directors. Such shares were not previously issued due to an inadvertent clerical error. Read SEC document |
| October 13, 2023 Filed Oct 17, 2023 23:52 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 25 | $150.47 | $3,761.75 |
DisclosureSEC source: 0001104659-23-109697 · tm2328548-6_4seq1.xml · nonDerivative · entry 1 Sparks Charisse Y · CIK 0001940873 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 893 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| October 12, 2023 Filed Jan 24, 2024 21:32 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | PurchaseCommon Stock | 100 | $153.50 | $15,350.00 |
DisclosureSEC source: 0001104659-24-006280 · tm244034-1_4seq1.xml · nonDerivative · entry 1 Sparks Charisse Y · CIK 0001940873 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 998 Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 20:07 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantEmployee Stock Option (Right to Buy) · Derivative | 4,452 | $0.00 Strike: $287.81 | $0.00 |
DisclosureSEC source: 0001104659-23-086794 · tm2322533-4_4seq1.xml · derivative · entry 1 Sparks Charisse Y · CIK 0001940873 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,452 Underlying: Common Stock · 4,452 shares Expires 2033-07-31 F1 · derivative.exercise_date: The option has vested or will vest and become exercisable as to 25% of the underlying shares on the first anniversary of July 31, 2023 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| July 17, 2023 Filed Jul 19, 2023 20:43 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 40 | $325.91 | $13,036.40 |
DisclosureSEC source: 0001104659-23-082369 · tm2321602-1_4seq1.xml · nonDerivative · entry 1 Sparks Charisse Y · CIK 0001940873 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 868 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| April 27, 2023 Filed May 1, 2023 23:51 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 669 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-054650 · tm2314266-8_4seq1.xml · nonDerivative · entry 1 Sparks Charisse Y · CIK 0001940873 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 828 F1 · shares: Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date. Read SEC document |
| April 10, 2023 Filed Apr 12, 2023 20:09 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 56 | $231.77 | $12,979.12 |
DisclosureSEC source: 0001104659-23-044582 · tm2312581-5_4seq1.xml · nonDerivative · entry 1 Sparks Charisse Y · CIK 0001940873 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 159 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| January 10, 2023 Filed Jan 20, 2023 00:54 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 52 | $248.31 | $12,912.12 |
DisclosureSEC source: 0001104659-23-005112 · tm233800-2_4seq1.xml · nonDerivative · entry 1 Sparks Charisse Y · CIK 0001940873 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| October 11, 2022 Filed Oct 13, 2022 20:20 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 51 | $168.98 | $8,617.98 |
DisclosureSEC source: 0001104659-22-108501 · tm2228171-3_4seq1.xml · nonDerivative · entry 1 Sparks Charisse Y · CIK 0001940873 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| July 28, 2022 Filed Aug 3, 2022 22:30 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantEmployee Stock Option (Right to Buy) · Derivative | 1,823 | $0.00 Strike: $208.50 | $0.00 |
DisclosureSEC source: 0001104659-22-085737 · tm2222455-2_4seq1.xml · derivative · entry 1 Sparks Charisse Y · CIK 0001940873 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,823 Underlying: Common Stock · 1,823 shares Expires 2032-07-28 F1 · derivative.exercise_date: The option vests and becomes exercisable in three equal annual installments beginning on July 28, 2023, subject to the Reporting Person's continuous service to the Issuer through each such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.